News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Cherington Charles
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Bought options to buy
@ $3300000, valued at
$0
Bought 2,307,692 warrants
@ $0.125, valued at
$288.5k
|
|
| 08/25/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Bought 880,195 shares
@ $0.5113, valued at
$450k
Bought 2,200,488 options to buy
@ $0.6135, valued at
$1.3M
|
|
| 01/06/2023 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Bought 743,243 shares
@ $1.23, valued at
$914.2k
Bought 743,243 options to buy
@ $1.23, valued at
$914.2k
|
|
| 12/06/2022 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Eterna Therapeutics Inc.|
Txns:
| Bought 261,756 shares
@ $3.28, valued at
$858.6k
Bought 523,512 warrants
@ $0.125, valued at
$65.4k
|
|
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2022 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Bought 10,481 shares
@ $1.6589, valued at
$17.4k
|
|
| 09/30/2022 |
4
| Cherington Charles (10% Owner) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Bought 17,900 shares
@ $1.8702, valued at
$33.5k
|
|
| 09/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Cherington Charles (Director) has filed a Form 4 on Brooklyn ImmunoTherapeutics, Inc.|
Txns:
| Granted 215,100 options to buy
@ $0.49, valued at
$105.4k
Granted 165,800 options to buy
@ $0.49, valued at
$81.2k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|